0001708138-20-000105.txt : 20200923
0001708138-20-000105.hdr.sgml : 20200923
20200923160051
ACCESSION NUMBER: 0001708138-20-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200921
FILED AS OF DATE: 20200923
DATE AS OF CHANGE: 20200923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L
CENTRAL INDEX KEY: 0001225474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201192118
MAIL ADDRESS:
STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS
STREET 2: 5323 HARRY HINES BLVD
CITY: DALLAS
STATE: TX
ZIP: 75390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-09-21
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001225474
GOLDSTEIN JOSEPH L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-09-21
4
M
0
3784
371.4
A
9427
D
Common Stock
2020-09-21
4
M
0
4960
380.95
A
14387
D
Common Stock
2020-09-21
4
M
0
7830
376.69
A
22217
D
Common Stock
2020-09-21
4
S
0
300
543.19
D
21917
D
Common Stock
2020-09-21
4
S
0
700
544.96
D
21217
D
Common Stock
2020-09-21
4
S
0
800
546.01
D
20417
D
Common Stock
2020-09-21
4
S
0
1356
547.28
D
19061
D
Common Stock
2020-09-21
4
S
0
3654
548.13
D
15407
D
Common Stock
2020-09-21
4
S
0
2600
549.07
D
12807
D
Common Stock
2020-09-21
4
S
0
1600
550.11
D
11207
D
Common Stock
2020-09-21
4
S
0
1501
551.09
D
9706
D
Common Stock
2020-09-21
4
S
0
513
552.01
D
9193
D
Common Stock
2020-09-21
4
S
0
1101
553.17
D
8092
D
Common Stock
2020-09-21
4
S
0
899
554.82
D
7193
D
Common Stock
2020-09-21
4
S
0
1530
555.74
D
5663
D
Common Stock
2020-09-22
4
S
0
20
552.36
D
5643
D
Non-Qualified Stock Option (right to buy)
371.4
2020-09-21
4
M
0
3784
0.0
D
2029-01-02
Common Stock
3784
0
D
Non-Qualified Stock Option (right to buy)
376.69
2020-09-21
4
M
0
7830
0.0
D
2027-01-03
Common Stock
7830
0
D
Non-Qualified Stock Option (right to buy)
380.95
2020-09-21
4
M
0
4960
0.0
D
2028-01-02
Common Stock
4960
2479
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 300 shares of Company stock on September 21, 2020 at prices ranging from $542.66 to $543.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 700 shares of Company stock on September 21, 2020 at prices ranging from $544.49 to $545.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 800 shares of Company stock on September 21, 2020 at prices ranging from $545.56 to $546.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,356 shares of Company stock on September 21, 2020 at prices ranging from $546.57 to $547.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,654 shares of Company stock on September 21, 2020 at prices ranging from $547.61 to $548.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,600 shares of Company stock on September 21, 2020 at prices ranging from $548.62 to $549.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,600 shares of Company stock on September 21, 2020 at prices ranging from $549.62 to $550.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,501 shares of Company stock on September 21, 2020 at prices ranging from $550.64 to $551.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 513 shares of Company stock on September 21, 2020 at prices ranging from $551.69 to $552.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 21, 2020 at prices ranging from $552.69 to $553.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 899 shares of Company stock on September 21, 2020 at prices ranging from $554.32 to $555.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,530 shares of Company stock on September 21, 2020 at prices ranging from $555.51 to $556.04. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Joseph L. Goldstein
2020-09-23